West Nile Virus vaccine
AssigneeBoehringer Ingelheim Vetmedica GmbH
InventorsKristina J. Hennessy, Phillip Wayne Hayes
Life of this patent
Estimating the term…
Abstract
The invention provides for immunogenic compositions against West Nile Virus. The immunogenic compositions, in alternate embodiments, also include other equine pathogens. The West Nile Virus composition of the present invention advantageously provides for protection against North American Dominant West Nile Virus strains or isolates.
Claims4
An immunogenic composition comprising a strain of killed or inactivated West Nile Virus, wherein said West Nile Virus strain is Horse Origin 2005, also known as NAEE 159, deposited at the United States Department of Agriculture Isolate under accession number 405330 and also deposited with the ATCC under accession number PTA-9409;
- and one or more of the antigenic components selected from the group consisting of Equine Influenza Virus, deposited with the ATCC under accession numbers ATCC Accession No. PTA-9522, PTA-9523, and PTA-9524, Eastern Equine Encephalomyelitis Virus, deposited with the ATCC under accession number PTA-9412;
- Western Equine Encephalomyelitis Virus, deposited with the ATCC under accession number PTA-9410;
- Venezuelan Equine Encephalomyelitis Virus, deposited with the ATCC under accession number PTA-9411;
- Equine Herpes Virus Type 1, deposited with the ATCC under accession number PTA-9525, Equine Herpes Virus Type 4, deposited with the ATCC under accession number PTA-9526;
- and Tetanus toxoid.
A method of providing a duration of immunity of at least 12 months against West Nile Virus by administering at least one dose of a killed or inactivated West Nile Virus to a horse or herd of horses in need thereof, wherein said West Nile Virus strain is Horse Origin 2005, also known as NAEE I59, deposited at the United States Department of Agriculture Isolate under accession number 405330 and also deposited with the ATCC under accession number PTA-9409.
Dependencies are inferred from the claim text.